Whilst somatic mutations in FGFR3 and HRAS have previously been associated with SpTs [22,23], through the targeted screening of a panel of archival samples we identified two additional samples carrying a pathogenic mutation in NRAS; overall the mutation-positive tumours cluster significantly towards the older population of men with SpTs (Fig 1). The gene discussed is NRAS; the disease is neoplasm.